This new facility integrates multi-channel chip, micro-mixer system, and complex preparation system into a multi-channel micro-mixer core LNP manufacturing platform
Company will invest approximately ¥16 billion to increase production capacity by approximately 70% to ensure a stable supply
Condon joins DTx Pharma with more than 20 years of experience in business development, commercial planning, and operations.
The 41,000 sq ft facility will be utilized to manufacture clinical to commercial-grade peptide products for increased manufacturing capacity
Revenue from operations up 15% to Rs. 758 crore in fourth quarter
New line of Waters MaxPeak Premier columns further enhances the analysis by delivering 2x to 3x greater sensitivity than conventional steel columns
EUROAPI listing on Euronext Paris will occur in H1 2022, despite volatile market conditions
Biogen paid Ionis a US $ 60 million one-time upfront payment
The company is focused on the development of novel treatments for RNA viruses
Dicerna develops RNAi-based therapies to selectively silence genes that cause or contribute to disease
Subscribe To Our Newsletter & Stay Updated
